Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-008995
Filing Date
2022-03-08
Accepted
2022-03-08 07:09:20
Documents
89
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K agle-10k_20211231.htm   iXBRL 10-K 3865023
2 EX-10.20 agle-ex1020_196.htm EX-10.20 34864
3 EX-10.21 agle-ex1021_197.htm EX-10.21 103450
4 EX-21.1 agle-ex211_10.htm EX-21.1 15068
5 EX-23.1 agle-ex231_9.htm EX-23.1 2145
6 EX-31.1 agle-ex311_11.htm EX-31.1 15948
7 EX-31.2 agle-ex312_8.htm EX-31.2 15871
8 EX-32.1 agle-ex321_7.htm EX-32.1 6775
9 EX-32.2 agle-ex322_6.htm EX-32.2 6686
10 GRAPHIC g4ay4ov2ibw1000001.jpg GRAPHIC 20166
11 GRAPHIC ggjywcvftq5j000002.jpg GRAPHIC 18111
12 GRAPHIC ggjywcvftq5j000001.jpg GRAPHIC 56838
13 GRAPHIC g4ay4ov2ibw1000002.jpg GRAPHIC 17727
  Complete submission text file 0001564590-22-008995.txt   12952102

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA agle-20211231.xsd EX-101.SCH 66602
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agle-20211231_cal.xml EX-101.CAL 74290
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agle-20211231_def.xml EX-101.DEF 230360
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE agle-20211231_lab.xml EX-101.LAB 553290
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agle-20211231_pre.xml EX-101.PRE 417992
83 EXTRACTED XBRL INSTANCE DOCUMENT agle-10k_20211231_htm.xml XML 2508145
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37722 | Film No.: 22720314
SIC: 2834 Pharmaceutical Preparations